SIERRA ONCOLOGY : Reports Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib

Press/Media: Press / Media

PeriodDec 3 2018

Media coverage

1

Media coverage

  • TitleSIERRA ONCOLOGY : Reports Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib
    Media name/outletMarketScreener.com
    CountryUnited States
    Date12/3/18
    PersonsRuben Mesa